NOYO Investor Relations
Building the future of
global wellness.
NOYO is the only consumer wellness platform built under forensic psychiatric oversight, operating across 100 countries and more than 20 languages from day one. This is not a wellness app. This is infrastructure.
from day one
supported
clinical systems
subdomains
Mental health is the defining healthcare challenge of our era. More than one billion people worldwide live with a mental health condition. Less than 30 percent have access to any form of care. NOYO is built to close that gap at scale, with clinical rigour, cultural intelligence, and the infrastructure to sustain it.
Why NOYO. Why now.
A defining category, a clinical foundation
Six reasons NOYO is positioned to lead the next generation of global wellness infrastructure.
Pillar One
The opportunity
Mental health sits at the intersection of AI, clinical science, and global wellness at a moment when all three are converging. The market is massive, underserved, and shifting fast.
Pillar Two
The platform
32 interconnected subdomains, 100 countries, 20 plus languages, proprietary AI frameworks, and a tiered subscription model built for scale from the first user.
Pillar Three
Clinical differentiation
Built on proprietary frameworks: HAM, ERAS, CLPS, PGT, SCOM. Each is a distinct clinical system designed for trauma-informed, culturally adaptive, large-scale care.
Pillar Four
Global architecture
A single platform that adapts to local culture, language, and emotional context across 9 regions and 100 countries. Cultural intelligence is not a feature. It is the architecture.
Pillar Five
Revenue model
Diversified across direct consumer subscription tiers, enterprise licensing, institutional partnerships, a practitioner marketplace, and a curated wellness commerce stream.
Pillar Six
Leadership
Founded and led by a forensic psychiatrist. The clinical frameworks, technical architecture, and product design are all first-party. No outsourced foundations.
Business model
Five diversified revenue streams
NOYO is not dependent on a single revenue mechanism. Each stream is independently scalable and mutually reinforcing.
Competitive positioning
Why NOYO cannot be easily replicated
Existing wellness platforms
- Consumer apps with no clinical governance
- Single-language, single-market architecture
- No forensic psychiatric oversight
- Licensed third-party content, no proprietary IP
- Subscription-only revenue, no B2B licensing
- Crisis escalation is a feature, not a system
- Cultural adaptation is surface-level translation
NOYO
- Built under forensic psychiatric oversight
- 100 countries, 70 plus languages, natively
- Clinical governance embedded in architecture
- Seven proprietary licensed clinical systems
- Five diversified revenue streams, B2B and B2C
- ERAS and CIS as dedicated crisis infrastructure
- Cultural intelligence built into the data model
Platform overview
See what you are investing in
NOYO is a live, functioning platform. These are representative views of the architecture, AI intelligence systems, and user experience.
A platform built for scale from day one
NOYO is not a minimum viable product waiting to grow into global infrastructure. The architecture, the compliance frameworks, the cultural adaptation systems, and the clinical governance are in place before the first external user.
- 32 live subdomains, each purpose-built
- Tiered membership with clear unit economics
- Railway infrastructure with auto-deploy pipeline
- Supabase PostgreSQL with 19 deployed data blocks
- Mobile API in parallel development
AI companions built on clinical intelligence
NOYO AI companions are not chatbots with a wellness skin. They are trained on clinical frameworks developed under forensic psychiatric oversight, with crisis detection, cultural adaptation, and human escalation built into every interaction.
- Human Attunement Model governing all responses
- Real-time ERAS risk monitoring during sessions
- Automatic escalation to human practitioners
- Cultural and linguistic adaptation per user context
- 9,000 global companions across 24 wellness categories
Risk intelligence that healthcare enterprises can license
ERAS is a licensable clinical system. Healthcare systems, insurers, and forensic services can integrate real-time multi-domain risk scoring into their own workflows. This is a distinct B2B revenue stream with enterprise contract values.
- Multi-domain risk scoring in real time
- Four-level escalation protocol, automated
- Integration with EHR and triage systems
- Licensed separately to healthcare buyers
- Available in all 100 NOYO country markets
Cultural intelligence built into the architecture
Most platforms translate their product. NOYO adapts it. The Global Cultural Intelligence Engine adjusts content, tone, emotional framing, and clinical approach based on regional context, not just language. This is a proprietary competitive advantage that takes years to build.
- 9 global regions with dedicated cultural adaptation
- 70+ language stack with native rendering
- Content risk levels calibrated by region
- Cultural trauma language guide integrated
- White-label partners inherit the full stack
Pre-seed SAFE round
The ask is precise. The use of capital is defined.
NOYO is raising a pre-seed SAFE round to complete mobile development, expand the practitioner network, and accelerate the first enterprise licensing contracts. Capital efficiency has been a design constraint from the start. The infrastructure is live. We are funding growth, not construction.
Qualified investors receive the full deck, financial model, IP summary, and a direct conversation with leadership under mutual NDA. We are not broadcasting the round. We are selective about who we build with.
Leadership
Built by the person who designed it
NOYO was conceived, designed, and built by a forensic psychiatrist whose clinical background directly informs every framework, safety system, and product decision. The clinical architecture, the AI training methodology, the data governance model, and the cultural intelligence engine are all first-party intellectual property developed over years of practice and research.
For qualified investors
What you can request
All materials are available under mutual NDA to qualified investors. Contact us with your firm, thesis, and stage focus.